As a pioneer in the global diagnostics industry for over half a century, BBI Solutions is a leading manufacturer of critical reagents and a developer and manufacturer of point of care tests for the in-vitro diagnostics market.
During the Covid-19 pandemic, they were selected as a critical member of the UK Rapid Test Consortium (UK-RTC), a specialist group of companies tasked by the UK Government to develop a COVID-19 lateral flow antibody test, that people could use in their homes to determine if they had an antibody response to COVID-19.
BBI Solutions also developed their market position through growth and key acquisitions during this time. This rapid growth expedited the need to refresh and enhance their digital presence and redevelop their eCommerce website to reflect their innovation, global reach, and market position.